These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25556582)

  • 21. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
    Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the inducible nitric oxide synthase gene polymorphisms in Czech patients with atopic diseases.
    Holla LI; Stejskalova A; Znojil V; Vasku A
    Clin Exp Allergy; 2006 Dec; 36(12):1592-601. PubMed ID: 17177683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inducible nitric oxide synthase haplotype associated with hypertension and responsiveness to antihypertensive drug therapy.
    Oliveira-Paula GH; Lacchini R; Coeli-Lacchini FB; Junior HM; Tanus-Santos JE
    Gene; 2013 Feb; 515(2):391-5. PubMed ID: 23266817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of increased MYG1 expression and its promoter polymorphism with disease progression and higher susceptibility in vitiligo patients.
    Dwivedi M; Laddha NC; Begum R
    J Dermatol Sci; 2013 Sep; 71(3):195-202. PubMed ID: 23706493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt.
    Rahman HA; Khorshied MM; Khorshid OM; Mahgoub SM
    Ann Hematol; 2014 Nov; 93(11):1859-65. PubMed ID: 24912772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.
    Gonzalez-Gay MA; Llorca J; Sanchez E; Lopez-Nevot MA; Amoli MM; Garcia-Porrua C; Ollier WE; Martin J
    Rheumatology (Oxford); 2004 Sep; 43(9):1182-5. PubMed ID: 15226517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population.
    Tajouri L; Martin V; Ovcaric M; Curtain RP; Lea RA; Csurhes P; Pender MP; Griffiths LR
    Brain Res Bull; 2004 Jul; 64(1):9-13. PubMed ID: 15275951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.
    Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH
    J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The promoter of inducible nitric oxide synthase implicated in glaucoma based on genetic analysis and nuclear factor binding.
    Motallebipour M; Rada-Iglesias A; Jansson M; Wadelius C
    Mol Vis; 2005 Nov; 11():950-7. PubMed ID: 16288199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor-α and -β genetic polymorphisms as a risk factor in Saudi patients with vitiligo.
    Al-Harthi F; Zouman A; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2013 Jul; 12(3):2196-204. PubMed ID: 23884763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between catalase (CAT) gene polymorphisms and susceptibility to vitiligo in a Turkish population.
    Akbas H; Dertlioglu SB; Dilmec F; Balkan M
    Clin Ter; 2013; 164(3):e173-7. PubMed ID: 23868633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population.
    Dwivedi M; Laddha NC; Mansuri MS; Marfatia YS; Begum R
    Br J Dermatol; 2013 Nov; 169(5):1114-25. PubMed ID: 23773036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of association between catalase gene polymorphism (T/C exon 9) and susceptibility to vitiligo in a Turkish population.
    Bulut H; Pehlivan M; Alper S; Tomatir AG; Onay H; Yüksel SE; Ozkinay F; Pehlivan S
    Genet Mol Res; 2011 Oct; 10(4):4126-32. PubMed ID: 22058000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo].
    Zhou MN; Xu AE; Lu LJ; Li YW; Zhao DK; Guan CP
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):969-72. PubMed ID: 18756969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations.
    Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T
    J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence.
    Qidwai T; Jamal F
    Scand J Immunol; 2010 Nov; 72(5):375-87. PubMed ID: 21039732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. iNOS promoter variants and severe malaria in Ghanaian children.
    Cramer JP; Mockenhaupt FP; Ehrhardt S; Burkhardt J; Otchwemah RN; Dietz E; Gellert S; Bienzle U
    Trop Med Int Health; 2004 Oct; 9(10):1074-80. PubMed ID: 15482399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.
    Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E
    Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.